Ratio Review: Analyzing Sana Biotechnology Inc (SANA)’s Price-to-Cash and Price-to-Free Cash Flow

Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

After finishing at $6.40 in the prior trading day, Sana Biotechnology Inc (NASDAQ: SANA) closed at $6.15, down -3.91%. In other words, the price has decreased by -$3.91 from its previous closing price. On the day, 1.16 million shares were traded. SANA stock price reached its highest trading level at $6.46 during the session, while it also had its lowest trading level at $6.0.

Ratios:

Our goal is to gain a better understanding of SANA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.07 and its Current Ratio is at 6.07. In the meantime, Its Debt-to-Equity ratio is 0.28 whereas as Long-Term Debt/Eq ratio is at 0.25.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on June 26, 2024, initiated with a Buy rating and assigned the stock a target price of $16.

On January 16, 2024, H.C. Wainwright Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $12.

On September 25, 2023, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $9.JMP Securities initiated its Mkt Outperform rating on September 25, 2023, with a $9 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 08 ’24 when Yang Patrick Y sold 25,000 shares for $9.45 per share. The transaction valued at 236,300 led to the insider holds 149,250 shares of the business.

NELSEN ROBERT bought 1,818,181 shares of SANA for $9,999,996 on Feb 08 ’24. The Director now owns 12,446,022 shares after completing the transaction at $5.50 per share. On Feb 08 ’24, another insider, ARCH Venture Fund X, L.P., who serves as the 10% Owner of the company, bought 1,818,181 shares for $5.50 each. As a result, the insider paid 9,999,996 and bolstered with 12,446,022 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SANA now has a Market Capitalization of 1362243584 and an Enterprise Value of 1157249920.

Stock Price History:

Over the past 52 weeks, SANA has reached a high of $12.00, while it has fallen to a 52-week low of $2.74. The 50-Day Moving Average of the stock is -6.75%, while the 200-Day Moving Average is calculated to be -3.87%.

Shares Statistics:

The stock has traded on average 1.94M shares per day over the past 3-months and 2050500 shares per day over the last 10 days, according to various share statistics. A total of 197.86M shares are outstanding, with a floating share count of 120.52M. Insiders hold about 45.59% of the company’s shares, while institutions hold 50.27% stake in the company. Shares short for SANA as of 1721001600 were 27881909 with a Short Ratio of 14.37, compared to 1718323200 on 24409153. Therefore, it implies a Short% of Shares Outstanding of 27881909 and a Short% of Float of 26.240000000000002.

Most Popular